Grant McFadden's guest appearances

Grant McFadden

The Andrew DeWitt Show

Ask A Biologist

Science to Business Network (S2BN) Podcast

AZ Tech Podcast

Robert Krulwich

Andrew Smith

Richard Branson

Melissa Wilson

Andre Hyland

Kevin Folta

Brian Smith

Barbara Gray

Tess Barker

Jeff Danis

Ryan O'Neill

Jerry Rocha

James Collins

John Roy

Raj Desai

OwlTail

Dr. Grant McFadden is trying to find out if a virus fatal only to rabbits might also destroy cancer cells. He became interested in the myxoma virus in grad school. The virus was first released in Australia in the 1950s to try to control a massive rabbit population . Since then, Grant has turned his interest into a lifelong pursuit of understanding viruses. Now, as a virologist and researcher at ASU's Biodesign Institute, he's altering viruses and learning how these viruses could treat cancer. In this episode, Dr. McFadden tells Hamid about his research and discusses the importance of the FDA and the development and safety of the Covid-19 vaccines.Watch the interview on YouTube: https://youtu.be/jOYnyjPsF-U

Dr. Grant McFadden is trying to find out if a virus fatal only to rabbits might also destroy cancer cells. He became interested in the myxoma virus in grad school. The virus was first released in Australia in the 1950s to try to control a massive rabbit population . Since then, Grant has turned his interest into a lifelong pursuit of understanding viruses. Now, as a virologist and researcher at ASU's Biodesign Institute, he's altering viruses and learning how these viruses could treat cancer. In this episode, Dr. McFadden tells Hamid about his research and discusses the importance of the FDA and the development and safety of the Covid-19 vaccines. Watch the interview on YouTube: <a href="https://youtu.be/jOYnyjPsF-U" rel="nofollow" target="_blank">https://youtu.be/jOYnyjPsF-U</a>

Grant McFadden, Researcher, ASU Biodesign Institute

Biography: Grant McFadden (Professor, Arizona State University)Dr. Grant McFadden is one of the top global leaders in oncolytic viruses with a specialization in pox viruses, including myxoma. Grant is a Founder, Research Advisor &amp; Director of Oncomyx Therapeutics which is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer.  He was inducted as a Fellow of the Royal Society of Canada in 2004, the Canadian Academy of Health Sciences in 2005 and the American Academy of Microbiology in 2007. Dr. McFadden is currently a Professor at Arizona State University and is the Director of the Biodesign Center for Immunotherapy, Vaccines, and Virotherapy (B-CIVV). He is the co-Editor-in-Chief of the journal PLoS Pathogens, a Senior Editor at Journal of Molecular Therapy – Oncolytics and was the President of the American Society for Virology 2015-16. Grant’s lab studies how poxviruses that cause immunosuppression interact with the host immune system. The McFadden lab pioneered the field of viral immune subversion (also called “anti-immunology”) and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system. His lab also investigates host-virus tropism, and the deployment of poxviruses for oncolytic virotherapy for the treatment of cancer, particularly with a rabbit-specific poxvirus called myxoma virus (MYXV). Grant has published over 340 scientific papers and reviews. He earned a BSc and PhD in Biochemistry from McGill University.

Biography: Grant McFadden (Professor, Arizona State University)Dr. Grant McFadden is one of the top global leaders in oncolytic viruses with a specialization in pox viruses, including myxoma. Grant is a Founder, Research Advisor &amp; Director of Oncomyx Therapeutics which is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer.  He was inducted as a Fellow of the Royal Society of Canada in 2004, the Canadian Academy of Health Sciences in 2005 and the American Academy of Microbiology in 2007. Dr. McFadden is currently a Professor at Arizona State University and is the Director of the Biodesign Center for Immunotherapy, Vaccines, and Virotherapy (B-CIVV). He is the co-Editor-in-Chief of the journal PLoS Pathogens, a Senior Editor at Journal of Molecular Therapy – Oncolytics and was the President of the American Society for Virology 2015-16. Grant’s lab studies how poxviruses that cause immunosuppression interact with the host immune system. The McFadden lab pioneered the field of viral immune subversion (also called “anti-immunology”) and is credited with the discovery of a wide spectrum of virus-derived inhibitors of the immune system. His lab also investigates host-virus tropism, and the deployment of poxviruses for oncolytic virotherapy for the treatment of cancer, particularly with a rabbit-specific poxvirus called myxoma virus (MYXV). Grant has published over 340 scientific papers and reviews. He earned a BSc and PhD in Biochemistry from McGill University.

Grant McFadden - A Pox on Your Cancer